Serum concentrations of pegylated interferon alpha-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon alpha-2b in a randomized phase III trial (EORTC 18991).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples